Patheon to Present at ExL Pharma’s 2nd Enhancing Drug Bioavailability and Solubility Conference

A presentation “Solid Dispersion Techniques for Enhancing Solubility” will be given by Jason M. Vaughn, Ph.D., Director, Formulations and Process Development, Pharmaceutical Development Services, Patheon Inc. on Tuesday, January 22, 2013 at 4:10 p.m. Eastern Time.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) January 14, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will present at ExL Pharma’s 2nd Enhancing Drug Bioavailability and Solubility Conference in Boston, Massachusetts.

A presentation “Solid Dispersion Techniques for Enhancing Solubility” will be given by Jason M. Vaughn, Ph.D., Director, Formulations and Process Development, Pharmaceutical Development Services, Patheon Inc. on Tuesday, January 22, 2013 at 4:10 p.m. Eastern Time. For more information on upcoming events, visit http://www.patheon.com/Knowledge-Library/Events.aspx.

Patheon representatives will also be available to meet at the Enhancing Drug Bioavailability and Solubility conference from January 21-23, 2013, showcasing several of Patheon’s key service offerings, including SoluPath™ - an innovative and cost-effective service used to identify an optimal drug delivery system for compounds with poor bioavailability. In a recent case study, SoluPath™ improved bioavailability by four times in just three months. Learn more by visiting Patheon’s booth during the conference or by visiting the company’s website at http://www.patheon.com/Services/UniqueSolutions/SoluPath.aspx.    

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated development and manufacturing network consists of thirteen manufacturing facilities and eleven development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.